Stock Analysis·← Pickers

IINN

Inspira Technologies OXY B.H.N. Ltd.

Inspira Technologies OXY B.H.N. Ltd. (IINN) is currently in an uptrend, trading above both the 50-day and 200-day moving averages. RSI is at 50.9, with 3/3 trend checks passing.

Price
$1.61
2026-07-16
Trend score
3/3
Uptrend
RSI (14)
50.9
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

IINN with MA50 and MA200

3.082.391.691.000.3007/2210/1501/1204/0807/10
IINN2025-07-222026-07-10
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$1.24+29.44% vs price
MA200
$0.95+69.06% vs price
RSI (14)
50.9Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for IINN

Inspira Technologies OXY B.H.N. Ltd. (IINN) is still trading in a constructive trend overall. The latest available price is $1.61, and 3 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 29.4% and above the 200-day moving average by 69.1%.

Momentum and stretch context

IINN currently has an RSI reading of 50.9, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

For traders reviewing IINN next, the key question is whether the trend still looks healthy or whether price has started to outrun itself. A strong uptrend can stay strong, but entries often become more difficult when price is already extended, so many traders will watch for pullbacks, support reactions, or fresh bases rather than chasing strength blindly.

Company profile

About Inspira Technologies OXY B.H.N. Ltd.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers additive manufactured electronics platform that enables 3D architecture for systems operating in dilution cryostats. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.

Sector
Healthcare
Industry
Medical - Devices
CEO
Dagi Shahar Ben-Noon
Employees
39
Market cap
$38.8M
Beta
2.33
52-week range
$0.33 – $2.10
Dividend
No
Exchange
NASDAQ
Country
IL
IPO date
14 Jul 2021
ISIN
IL0011715781
CUSIP
M5S26K102
Company profile data from Financial Modeling Prep. IINN listed on NASDAQ.
Share dilution

IINN shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Mar 2019Jun 2025
Shares outstanding (latest)
26.8M
Since Mar 2019
+1306.7%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. IINN24 data points from Mar 2019 to Jun 2025.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about IINN

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.